Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
J Codony-Servat, MA Tapia, M Bosch, C Oliva… - Molecular cancer …, 2006 - AACR
The cellular and molecular effects of the proteasome inhibitor bortezomib on breast cancer
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
J Codony-Servat, MA Tapia… - Molecular cancer …, 2006 - pubmed.ncbi.nlm.nih.gov
The cellular and molecular effects of the proteasome inhibitor bortezomib on breast cancer
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
J Codony-Servat, MA Tapia, M Bosch, C Oliva… - Molecular Cancer …, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The cellular and molecular effects of the
proteasome inhibitor bortezomib on breast cancer cells are as yet poorly characterized …
proteasome inhibitor bortezomib on breast cancer cells are as yet poorly characterized …
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
J Codony-Servat, MA Tapia… - Molecular cancer …, 2006 - mayoclinic.elsevierpure.com
The cellular and molecular effects of the proteasome inhibitor bortezomib on breast cancer
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …
[PDF][PDF] Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
J Codony-Servat, MA Tapia, M Bosch, C Oliva… - Mol Cancer …, 2006 - researchgate.net
The cellular and molecular effects of the proteasome inhibitor bortezomib on breast cancer
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells.
J Codony-Servat, MA Tapia, M Bosch… - Molecular Cancer …, 2006 - europepmc.org
The cellular and molecular effects of the proteasome inhibitor bortezomib on breast cancer
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …
cells are as yet poorly characterized. Here, in a panel of six breast cancer cell lines …